142 related articles for article (PubMed ID: 14562907)
21. Evaluation of antibody response to vaccination against West Nile virus in thick billed parrots (Rhynchopsitta pachyrhyncha).
Glavis J; Larsen RS; Lamberski N; Gaffney P; Gardner I
J Zoo Wildl Med; 2011 Sep; 42(3):495-8. PubMed ID: 22950325
[TBL] [Abstract][Full Text] [Related]
22. Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection.
Chang GJ; Davis BS; Stringfield C; Lutz C
Vaccine; 2007 Mar; 25(12):2325-30. PubMed ID: 17224209
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of three vaccines in protecting Western Scrub-Jays (Aphelocoma californica) from experimental infection with West Nile virus: implications for vaccination of Island Scrub-Jays (Aphelocoma insularis).
Wheeler SS; Langevin S; Woods L; Carroll BD; Vickers W; Morrison SA; Chang GJ; Reisen WK; Boyce WM
Vector Borne Zoonotic Dis; 2011 Aug; 11(8):1069-80. PubMed ID: 21438693
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of West Nile virus neutralizing antibodies in wild birds from the Camargue area, southern France.
Jourdain E; Zeller HG; Sabatier P; Murri S; Kayser Y; Greenland T; Lafaye M; Gauthier-Clerc M
J Wildl Dis; 2008 Jul; 44(3):766-71. PubMed ID: 18689669
[TBL] [Abstract][Full Text] [Related]
25. West Nile virus in raptors from Virginia during 2003: clinical, diagnostic, and epidemiologic findings.
Joyner PH; Kelly S; Shreve AA; Snead SE; Sleeman JM; Pettit DA
J Wildl Dis; 2006 Apr; 42(2):335-44. PubMed ID: 16870856
[TBL] [Abstract][Full Text] [Related]
26. Pathology and epidemiology of natural West Nile viral infection of raptors in Georgia.
Ellis AE; Mead DG; Allison AB; Stallknecht DE; Howerth EW
J Wildl Dis; 2007 Apr; 43(2):214-23. PubMed ID: 17495305
[TBL] [Abstract][Full Text] [Related]
27. Ophthalmologic and oculopathologic findings in red-tailed hawks and Cooper's hawks with naturally acquired West Nile virus infection.
Pauli AM; Cruz-Martinez LA; Ponder JB; Redig PT; Glaser AL; Klauss G; Schoster JV; Wünschmann A
J Am Vet Med Assoc; 2007 Oct; 231(8):1240-8. PubMed ID: 17937556
[TBL] [Abstract][Full Text] [Related]
28. Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).
Jarvi SI; Lieberman MM; Hofmeister E; Nerurkar VR; Wong T; Weeks-Levy C
Vaccine; 2008 Oct; 26(42):5338-44. PubMed ID: 18723064
[TBL] [Abstract][Full Text] [Related]
29. WEST NILE VIRUS SEROCONVERSION IN EASTERN LOGGERHEAD SHRIKE (
Schutten K; Chabot A; Wheeler H
J Zoo Wildl Med; 2021 Apr; 52(1):185-191. PubMed ID: 33827175
[TBL] [Abstract][Full Text] [Related]
30. Low West Nile virus circulation in wild birds in an area of recurring outbreaks in Southern France.
Balança G; Gaidet N; Savini G; Vollot B; Foucart A; Reiter P; Boutonnier A; Lelli R; Monicat F
Vector Borne Zoonotic Dis; 2009 Dec; 9(6):737-41. PubMed ID: 19402766
[TBL] [Abstract][Full Text] [Related]
31. West Nile Virus Infection in Ruffed Grouse ( Bonasa umbellus): Experimental Infection and Protective Effects of Vaccination.
Nemeth NM; Bosco-Lauth AM; Williams LM; Bowen RA; Brown JD
Vet Pathol; 2017 Nov; 54(6):901-911. PubMed ID: 28675106
[TBL] [Abstract][Full Text] [Related]
32. Vaccination of captive nēnē (Branta sandvicensis) against West Nile virus using a protein-based vaccine (WN-80E).
Jarvi SI; Hu D; Misajon K; Coller BA; Wong T; Lieberman MM
J Wildl Dis; 2013 Jan; 49(1):152-6. PubMed ID: 23307381
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
[TBL] [Abstract][Full Text] [Related]
34. Natural and experimental West Nile virus infection in five raptor species.
Nemeth N; Gould D; Bowen R; Komar N
J Wildl Dis; 2006 Jan; 42(1):1-13. PubMed ID: 16699143
[TBL] [Abstract][Full Text] [Related]
35. An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application.
Samina I; Khinich Y; Simanov M; Malkinson M
Vaccine; 2005 Sep; 23(41):4955-8. PubMed ID: 16023273
[TBL] [Abstract][Full Text] [Related]
36. A live attenuated West Nile virus strain as a potential veterinary vaccine.
Lustig S; Olshevsky U; Ben-Nathan D; Lachmi BE; Malkinson M; Kobiler D; Halevy M
Viral Immunol; 2000; 13(4):401-10. PubMed ID: 11192286
[TBL] [Abstract][Full Text] [Related]
37. Protection of horses from West Nile virus Lineage 2 challenge following immunization with a whole, inactivated WNV lineage 1 vaccine.
Bowen RA; Bosco-Lauth A; Syvrud K; Thomas A; Meinert TR; Ludlow DR; Cook C; Salt J; Ons E
Vaccine; 2014 Sep; 32(42):5455-9. PubMed ID: 25131745
[TBL] [Abstract][Full Text] [Related]
38. Views WNV prevention suggestions as outdated.
Reilly FK
J Am Vet Med Assoc; 2004 Oct; 225(7):1027-8. PubMed ID: 15515977
[No Abstract] [Full Text] [Related]
39. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
[TBL] [Abstract][Full Text] [Related]
40. West Nile virus vaccines.
Hall RA; Khromykh AA
Expert Opin Biol Ther; 2004 Aug; 4(8):1295-305. PubMed ID: 15268663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
